Table 4.

Performance of the different diagnostic approaches in a population of 100 000 tested individuals based on the validation cohort measures

VariablePer 100 000 patients (60 myeloma cases), nRatio of false alarms to cancers diagnosedRatio of true negatives to cancers missed
Cancers diagnosedFalse alarmsCancers missedCorrectly spared investigations
Symptoms
Back pain1389954790 945692 to 11935 to 1
Chest pain559965593 9441199 to 11708 to 1
Rib pain15005999 440500 to 11685 to 1
Nosebleeds18005999 140800 to 11680 to 1
FBC (index test)
Anaemia (any type)3416 9902682 950500 to 13190 to 1
Low platelets529985596 942600 to 11763 to 1
Low WCC429995696 941750 to 11731 to 1
High MCV1479954691 945571 to 11998 to 1
Other tests
Hypercalcemiaa419995697 941500 to 11748 to 1
High ESRa4844 9731254 967936 to 14581 to 1
High ESR or anaemiaa5449 970649 970925 to 18328 to 1
High ESR and anaemiaa2711 9933387 947444 to 12665 to 1
FBC model
Prevalence4822 9861276 954479 to 16412 to 1
90th percentile3799942389 946270 to 13910 to 1
95th percentile2549973594 943200 to 12712 to 1
99th percentile119994998 94191 to 12019 to 1
All-test modela
Prevalence5016 0901083 850322 to 18385 to 1
90th percentile4399941789 946232 to 15290 to 1
95th percentile3749972394 943135 to 14127 to 1
99th percentile209994098 94125 to 12473 to 1
  • a Corresponds to the performance measures if ESR and calcium were to be ordered for all patients in the sample. ESR = erythrocyte sedimentation rate. FBC = full blood count.

  • MCV = mean corpuscular volume. WCC = white cell count.